Ambu A/S/DKr AMBU B
1D1W1MYTD1Y5YMAX
Capital at risk
About Ambu A/S
Ambu A/S is a Danish company operating in the medical device industry, focusing on the development and marketing of products for hospitals and healthcare providers. The company specializes in anesthesiology, patient monitoring and diagnostics, and emergency care solutions. Some of Ambu's key products include single-use endoscopes, resuscitators, and electrodes for patient monitoring. Founded in 1937, Ambu is headquartered in Ballerup, Denmark, and serves a global market with a significant presence in Europe, North America, and Asia. The company is known for its strategic emphasis on innovation in single-use devices, which helps reduce the risk of cross-contamination and improves healthcare efficiency.
- Ticker
- DKr AMBU B
- Sector
- Health
- Primary listing
- CSE
- Employees
- 5,200
- Headquarters
- Ballerup, Denmark
- Website
- www.ambu.com
Ambu A/S Metrics
BasicAdvanced
kr 17B
33.94
kr 1.92
1.39
kr 0.41
0.63%
Price and volume
Market cap
kr 17B
Beta
1.39
52-week high
kr 111.80
52-week low
kr 56.25
Average daily volume
944K
Dividend rate
kr 0.41
Financial strength
Current ratio
2.77
Quick ratio
1.58
Long term debt to equity
0.08
Total debt to equity
0.094
Dividend payout ratio (TTM)
21.57%
Interest coverage (TTM)
15.67%
Profitability
EBITDA (TTM)
869
Gross margin (TTM)
60.11%
Net profit margin (TTM)
8.18%
Operating margin (TTM)
11.30%
Effective tax rate (TTM)
23.08%
Revenue per employee (TTM)
kr 1,200,000
Management effectiveness
Return on assets (TTM)
5.81%
Return on equity (TTM)
8.45%
Valuation
Price to earnings (TTM)
33.939
Price to revenue (TTM)
2.768
Price to book
2.79
Price to tangible book (TTM)
6.12
Price to free cash flow (TTM)
43.059
Free cash flow yield (TTM)
2.32%
Free cash flow per share (TTM)
1.513
Dividend yield (TTM)
0.63%
Forward dividend yield
0.63%
Growth
Revenue change (TTM)
4.68%
Earnings per share change (TTM)
43.07%
3-year revenue growth (CAGR)
10.05%
10-year revenue growth (CAGR)
11.79%
3-year earnings per share growth (CAGR)
127.63%
10-year earnings per share growth (CAGR)
7.82%
10-year dividend per share growth (CAGR)
7.99%
Bulls say / Bears say
Ambu delivered 7.3% organic revenue growth in Q2 2025/26, driven by a 13.8% increase in its market-leading Endoscopy Solutions segment, underscoring robust demand for single-use endoscopes. (Reuters)
Management maintained its full-year FY 2025/26 guidance for organic revenue growth of 10–12% and an EBIT margin of 12–14%, signaling confidence in its operational outlook amid market headwinds. (Reuters)
Ambu initiated a new share buyback program to repurchase up to DKK 300 million in shares from 6 May 2026 until 30 September 2026, demonstrating management’s commitment to shareholder returns and belief in the company’s valuation. (Ritzau)
Its Anesthesia & Patient Monitoring business declined by 2.5% in Q2, highlighting weakness in its legacy segments that could pressure near-term growth. (Reuters)
Reported Q2 EBIT margin was 11.0%, below the company’s 12–14% guidance range, indicating profitability underperformance and potential margin compression. (Reuters)
Adjusted operating profit for Q2 fell short of market forecasts, reflecting profitability headwinds from tariffs and foreign exchange challenges. (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 26 Aug 2026.
Upcoming events
No upcoming events
Funds containing Ambu A/S
AllEURGBPUSD
Fund name | Fund size | DKr AMBU B weighting |
|---|---|---|
Xtrackers MSCI Europe Small Cap€DX2J | €3.2B | 0.12% |
Xtrackers MSCI Europe Small Cap£XXSC | £2.8B | 0.12% |
Amundi STOXX Europe 600 ESG€C6E | €735M | 0.03% |
Amundi STOXX Europe 600€MEUD | €7.6B | 0.02% |
iShares MSCI World Small Cap$WSML | $9B | 0.02% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.